{
    "SPADE_N_13596": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13596",
            "Peptide Name": "Arenicin-3 (Ar-3, NZ17000; UCSS1a; 2S=S, natural AMPs; marine polychaeta, annelid worm, invertebrates, animals; derivatives: NZ17074)",
            "Source": "the lugworm,Arenicola marina",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GFCWYVCYRNGVRVCYRRCN",
            "Sequence Length": 20,
            "UniProt Entry": "",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2517.93,
            "PI": 9.25,
            "Hydrophobicity": -0.26,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Hoegenhaug HK, Holte S, Mygind PH, Kruse T, Segura DR, Kyst R, Sandvang DH, Neve S. 2011",
                    "Reference": "US patent. (Hoegenhaug et al. 2011)",
                    "Title": "ANTMICROBAL PEPTDEVARIANTS AND POLYNUCLEOTDESENCODING SAME"
                }
            ],
            "Frequent Amino Acids": "CRV",
            "Absent Amino Acids": "ADEHIKLMOPQSTU",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 16,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that the sequence of the peptide shows 55% similarity toTachyplesin I.Activity: Active against E. coli ATCC 25922 (MIC 1 ug/ml), K. pneumoniae ATCC13883 (MIC 2 ug/ml), A. baumannii ATCC19606 (MIC 0.5 ug/ml), and P. aeruginosa ATCC27853 (MIC 2 ug/ml).Animal model:mouse: the peptide showed in vivo efficacy against E. coli when i.v. or i.p. injected.  A significant (p<0.001) reduction of more the 3 logo CFU/ml compared to vehicle treatment was observed for NZ17074 in blood and peritoneal fluid at 5 hours after treatment.Structure: refined by NMR: 100% in most favored Ramachandran region (Elliott et al., 2020).You can rotate, zoom, and view the 3D structureherein the PDB.Updated 7/2021; 12/2021; 5/2024",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15887",
                    "Similarity": 1.0,
                    "Sequence": "GFCWYVCVYRNGVRVCYRRCN"
                },
                {
                    "SPADE_ID": "SPADE_UN_06006",
                    "Similarity": 1.0,
                    "Sequence": "GFCWYVCVYRNGVRVCYRRCN"
                },
                {
                    "SPADE_ID": "SPADE_UN_06025",
                    "Similarity": 1.0,
                    "Sequence": "GFCWYVCAYRNGVRVCYRRCN"
                }
            ]
        }
    }
}